Publication | Closed Access
<i>UGT1A1*28</i> Genotype Predicts Gastrointestinal Toxicity in Patients Treated With Intermediate-Dose Irinotecan
34
Citations
20
References
2009
Year
Our findings indicate that UGT1A1 genotyping is not a good predictor of hematological toxicity in patients treated with intermediate irinotecan doses. However, it may be useful in the identification of patients at risk of severe diarrhea.
| Year | Citations | |
|---|---|---|
Page 1
Page 1